Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Investigator from Dana–Farber Cancer Institute

Nursing Oncology Capacity Building through Fellowship Programs in Rwanda and Haiti

Non-Hodgkin lymphoma

Franziska Michor

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Stanley R. Riddell

Targeted therapy of B cell malignances with CAR-T cells of defined composition

Non-Hodgkin lymphoma Leukaemia

A. Thomas Look

Discovery of New Targets and Pathways for T-ALL Therapy

Leukaemia

Christopher S Carlson

Monitoring disease progression in follicular lymphoma with next-gen sequencing

Non-Hodgkin lymphoma

Pathology

Leslie Kean

American Society of Hematology's Project at the Angkor Hospital for Children in Siem Reap, Cambodia

Leukaemia

Pediatric oncology or childhood cancer Hematology and hematologic malignancies

Corey Casper

Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)

Hodgkin lymphoma Non-Hodgkin lymphoma